Stocks
Agios Pharmaceuticals (AGIO) EBITDA US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | -418.2 | -309.5 | -385.1 | -526.8 | -384.9 | -390.2 | ||
| Changes by years, y/y, % | +15% | -26% | +24% | +37% | -27% | +1.2% | |||
Agios Pharmaceuticals. EBITDA US GAAP, bln rub
Agios Pharmaceuticals. EBITDA US GAAP, changes, %
Agios Pharmaceuticals. EBITDA US GAAP, sum by quarters, bln rub
Agios Pharmaceuticals (AGIO) EBITDA US GAAP (quarter values) |
||||||||
| 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
| EBITDA, bln rub | ? | -90.6 | -93.7 | -100.9 | -104.9 | -90.7 | -390.2 | |
| Changes by years, y/y, % | -11% | -4% | +8% | -53% | +0% | |||
| Changes by quarters, q/q, % | -60% | +3% | +8% | +4% | -13% | |||
